Matrizyme Pharma Overview
- Year Founded
-
2003
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Financing Rounds
-
3
Matrizyme Pharma General Information
Description
Developer of licensed and patented pharmaceutical drugs intended to facilitate angioplasty. The company operates as a privately-held biopharmaceutical firm that specializes in developing medicinal drugs, through the use of advanced therapeutics focusing on the area of interventional cardiology, by developing a drug that uses collagenase, enabling patients suffering from chronic total occlusions of coronary arteries to get easier stenting procedures.
Contact Information
Website
www.matrizyme.comCorporate Office
- 512-555 Richmond Street West
- Toronto, Ontario M5V 3B1
- Canada
Corporate Office
- 512-555 Richmond Street West
- Toronto, Ontario M5V 3B1
- Canada
Matrizyme Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Matrizyme Pharma Patents
Matrizyme Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2589523-A1 | Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions | Active | 02-Dec-2004 | ||
| CA-2589523-C | Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions | Inactive | 02-Dec-2004 | ||
| EP-1827484-A1 | Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions | Active | 02-Dec-2004 | ||
| EP-1827484-A4 | Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions | Active | 02-Dec-2004 | ||
| EP-1827484-B1 | Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions | Inactive | 02-Dec-2004 | A61K38/4886 |
Matrizyme Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Matrizyme Pharma FAQs
-
When was Matrizyme Pharma founded?
Matrizyme Pharma was founded in 2003.
-
Where is Matrizyme Pharma headquartered?
Matrizyme Pharma is headquartered in Toronto, Canada.
-
What industry is Matrizyme Pharma in?
Matrizyme Pharma’s primary industry is Biotechnology.
-
Is Matrizyme Pharma a private or public company?
Matrizyme Pharma is a Private company.
-
What is Matrizyme Pharma’s current revenue?
The current revenue for Matrizyme Pharma is .
-
How much funding has Matrizyme Pharma raised over time?
Matrizyme Pharma has raised $9.2M.
-
Who are Matrizyme Pharma’s investors?
Ontario Bioscience Innovation Organization has invested in Matrizyme Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process